Related Experiment Video

Updated: Jun 27, 2026

Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma
06:21

Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma

Published on: November 19, 2019

Hdm2 is regulated by K-Ras and mediates p53-independent functions in pancreatic cancer cells

X Sui1, S Shin, R Zhang

  • 1Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Oncogene
|November 26, 2008
PubMed

Insights

Human double minute-2 protein (hdm2) drives pancreatic cancer growth independently of p53. Activated Ras signaling increases hdm2, which targets cyclin D1, c-Jun, and c-Myc to promote proliferation.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Genetics

Background:

  • The human double minute-2 protein (hdm2) has oncogenic functions beyond its interaction with tumor suppressor p53.
  • The role and regulation of hdm2 in pancreatic tumors, frequently harboring mutant p53, remain poorly understood.
  • Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal malignancy with limited therapeutic options.

Purpose of the Study:

  • To investigate the role and regulation of hdm2 in pancreatic cancer cells.
  • To determine if hdm2 exerts p53-independent functions in pancreatic cancer.
  • To identify novel hdm2 targets involved in pancreatic cancer progression.

Main Methods:

  • Utilized various pancreatic cancer cell lines.
  • Employed Ras signaling pathway analysis.
  • Performed hdm2-specific RNA interference (RNAi) and assessed proliferation/survival.
  • Investigated potential hdm2 targets including cyclin D1, c-Jun, and c-Myc.

Main Results:

  • hdm2 expression was found to be dependent on Ras signaling in pancreatic cancer cell lines.
  • hdm2 inhibition via RNAi significantly suppressed proliferation and survival, despite p53 mutation.
  • Cyclin D1, c-Jun, and c-Myc were identified as novel targets of hdm2.

Conclusions:

  • hdm2 is upregulated in pancreatic cancer cells due to activated Ras signaling.
  • hdm2 promotes pancreatic cancer cell proliferation and survival through p53-independent mechanisms.
  • hdm2 regulates novel target genes, including cyclin D1, c-Jun, and c-Myc, contributing to its oncogenic role.

More Related Videos

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity: